Literature DB >> 1398644

Pleomorphic variant of invasive lobular carcinoma of the breast.

N Weidner1, J P Semple.   

Abstract

Infiltrating lobular carcinoma (ILC) of the classic type is well recognized; less well appreciated is a group of variant forms of ILC, which includes solid, alveolar, mixed, apocrine, signet-ring, histiocytoid, and tubulolobular variants. In addition, Page et al (Diagnostic Histopathology of the Breast, Churchill Livingstone, 1987, pp 219-226) recently have emphasized the pleomorphic variant of ILC, which demonstrates the infiltrating pattern of classic ILC; however, the nuclei are more pleomorphic and have features that may overlap with those of infiltrating duct carcinoma. To determine whether pleomorphic ILC shows significant prognostic differences from classic ILC, we reviewed the clinical courses of 25 patients with classic ILC and compared them with 16 patients with pleomorphic ILC. The major determinant in placing ILC into the pleomorphic category was the presence of nuclei of nuclear grade 2 or 3. All classic ILCs had nuclei of grade 1 by the Scarff-Bloom-Richardson criteria. Survival to recurrence was significantly worse (P less than or equal to .05) for the patients with pleomorphic ILC at lengths of survival greater than 30 months. In addition, node-negative patients with pleomorphic ILC were four times more likely to experience recurrence than node-negative patients with classic ILC; those with positive nodes and pleomorphic histology were 30 times more likely to experience recurrence. Although there appeared to be a trend toward decreased overall length of survival for those patients with pleomorphic ILC when compared with patients with classic ILC, this difference was not statistically significant.

Entities:  

Mesh:

Year:  1992        PMID: 1398644     DOI: 10.1016/0046-8177(92)90035-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  The impact of large sections and 3D technique on the study of lobular in situ and invasive carcinoma of the breast.

Authors:  Maria P Foschini; Alberto Righi; Maria C Cucchi; Teresa Ragazzini; Stefano Merelli; Bruna Santeramo; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2005-12-03       Impact factor: 4.064

2.  Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.

Authors:  Sonia Narendra; Sarah M Jenkins; Andras Khoor; Aziza Nassar
Journal:  Ann Diagn Pathol       Date:  2015-01-22       Impact factor: 2.090

Review 3.  Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.

Authors:  Nuket Eliyatkın; Evrim Yalçın; Baha Zengel; Safiye Aktaş; Enver Vardar
Journal:  J Breast Health       Date:  2015-04-01

4.  Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.

Authors:  Gábor Cserni; Giuseppe Floris; Nektarios Koufopoulos; Anikó Kovács; Afroditi Nonni; Peter Regitnig; Anders Stahls; Zsuzsanna Varga
Journal:  Virchows Arch       Date:  2017-05-20       Impact factor: 4.064

5.  Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.

Authors:  Satomi Kasashima; Atsuhiro Kawashima; Yoh Zen; Satoru Ozaki; Masako Kobayashi; Akihiko Tsujibata; Hiroshi Minato
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

6.  Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu--a case report.

Authors:  Varsha Manucha; Natalya Khilko; Kathleen Reilly; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

7.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

8.  Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.

Authors:  Maria Vittoria Dieci; Enrico Orvieto; Massimo Dominici; PierFranco Conte; Valentina Guarneri
Journal:  Oncologist       Date:  2014-06-26

9.  Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.

Authors:  B Bier; A Douglas-Jones; M Tötsch; B Dockhorn-Dworniczak; W Böcker; B Jasani; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 10.  Lobular Carcinoma In Situ.

Authors:  Hannah Y Wen; Edi Brogi
Journal:  Surg Pathol Clin       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.